The penny stock we picked in October, Adeona Pharmaceuticals, Inc. (AMEX: AEN), developer of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses, has gained 328.81% since our alert. AEN has been given approval at yesterday’s special meeting of stockholders to change its corporate name to Synthetic Biologics, Inc.
AEN shares ...
Continue Reading →Two Penny Stocks to watch this week which could be long-term positions:
Adeona Pharmaceuticals is now covered by analysts at Chardan Capital Markets. The analysts set a “Buy” rating and a $1.00 price target on the stock.
Adeona Pharmaceuticals, Inc. operates as a pharmaceutical company that develops medicines for central nervous systems. AEN primarily focuses on licensing product candidates that have demonstrated a certain level of clinical ...
Continue Reading →